| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.94B | 29.95B | 25.71B | 22.35B | 19.41B | 16.43B |
| Gross Profit | 6.35B | 6.76B | 5.71B | 5.02B | 4.30B | 3.63B |
| EBITDA | 1.89B | 1.97B | 1.70B | 1.40B | 1.11B | 1.00B |
| Net Income | 1.20B | 1.24B | 1.03B | 861.93M | 688.00M | 571.10M |
Balance Sheet | ||||||
| Total Assets | 11.44B | 11.09B | 9.07B | 8.30B | 7.07B | 6.75B |
| Cash, Cash Equivalents and Short-Term Investments | 3.90B | 4.66B | 4.14B | 4.15B | 3.38B | 3.51B |
| Total Debt | 302.27M | 226.56M | 392.85M | 366.33M | 533.87M | 769.25M |
| Total Liabilities | 7.29B | 6.45B | 5.51B | 4.63B | 4.11B | 4.04B |
| Stockholders Equity | 4.15B | 4.64B | 3.55B | 3.67B | 2.95B | 2.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.66B | 1.26B | 1.16B | 665.79M | 1.13B |
| Operating Cash Flow | 0.00 | 1.85B | 1.43B | 1.31B | 766.23M | 1.17B |
| Investing Cash Flow | 0.00 | -577.61M | -359.56M | -142.52M | -198.22M | 21.66M |
| Financing Cash Flow | 0.00 | -768.70M | -1.07B | -397.36M | -701.04M | -421.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥56.15B | 20.65 | ― | 3.33% | 9.63% | 11.40% | |
71 Outperform | ¥20.94B | 14.17 | ― | 1.34% | 16.06% | 31.24% | |
71 Outperform | ¥11.32B | 14.99 | ― | 1.08% | 18.17% | 191.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥291.03B | 44.54 | ― | 0.87% | 16.30% | 23.34% |